CTRI Number |
CTRI/2023/11/060380 [Registered on: 30/11/2023] Trial Registered Prospectively |
Last Modified On: |
03/10/2023 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Preventive Screening Dentistry Behavioral |
Study Design |
Cluster Randomized Trial |
Public Title of Study
|
Effectiveness of an intervention package (oral self-examination, oral scrape cytology based screening and mHealth) to increase the oral cancer screening |
Scientific Title of Study
|
Development, field trial, effectiveness
and economic evaluation of an integrated public health intervention package to increase
the screening of oral cancer among adults residing in two districts of Madhya Pradesh
mixed methods implementation research study |
Trial Acronym |
NILL |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Sana Anwar |
Designation |
PhD scholar |
Affiliation |
AIIMS Bhopal |
Address |
Department of Community and Family Medicine,
2nd Floor, Hospital building, AIIMS Bhopal, Saket Nagar,
Bhopal
Bhopal MADHYA PRADESH 462020 India |
Phone |
9818526196 |
Fax |
|
Email |
sana.phd2022@aiimsbhopal.edu.in |
|
Details of Contact Person Scientific Query
|
Name |
Dr. Anindo Majumdar |
Designation |
Associate Professor |
Affiliation |
AIIMS Bhopal |
Address |
Department of Community and Family Medicine, Room no 16
2nd Floor, Hospital building, AIIMS Bhopal, Saket Nagar,
Bhopal Department of Community and Family Medicine, Room no 16
2nd Floor, Hospital building, AIIMS Bhopal, Saket Nagar,
Bhopal Bhopal MADHYA PRADESH 462020 India |
Phone |
9487635186 |
Fax |
|
Email |
anindo.cfm@aiimsbhopal.edu.in |
|
Details of Contact Person Public Query
|
Name |
Sana Anwar |
Designation |
PhD scholar |
Affiliation |
AIIMS Bhopal |
Address |
Department of Community and Family Medicine,
2nd Floor, Hospital building, AIIMS Bhopal, Saket Nagar,
Bhopal
Bhopal MADHYA PRADESH 462020 India |
Phone |
9818526196 |
Fax |
|
Email |
sana.phd2022@aiimsbhopal.edu.in |
|
Source of Monetary or Material Support
|
All India Institute of Medical Sciences ( AIIMS), Bhopal |
|
Primary Sponsor
|
Name |
Dr. Sana Anwar |
Address |
Department of community and family medicine,medical college building
saket nagar, AIIMS Bhopal, Bhopal- 462020 |
Type of Sponsor |
Other [pricipal investigator ( Dr. Sana Anwar)] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Sana Anwar |
AIIMS Bhopal |
Department of community and family medicine, second floor, Senior resident room,
Medical college building ,
Saket Nagar, AIIMS Bhopal
Bhopal.
462020 Bhopal MADHYA PRADESH |
9818526196
sana.phd2022@aiimsbhopal.edu.in |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Human Ethics Committee- student research ( IHEC- SR, AIIMS Bhopal) |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: C148||Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
intervention arm |
oral self-examination, oral scrape cytology based screening and mHealth). total duration of intervention is 1 year |
Comparator Agent |
usual care arm |
usual clinical care |
|
Inclusion Criteria
|
Age From |
30.00 Year(s) |
Age To |
99.00 Year(s) |
Gender |
Both |
Details |
1. Adults aged 30 years and above
2. Residing in the field practice areas of selected urban PHCs (UPHCs) which are not under CUHA, selected UPHCs under CUHA and PHC and CHC under CRHA. for most of the last six months.
3. Either owning a mobile phone themselves or having at least one member of their family living in the same household owning a mobile phone. |
|
ExclusionCriteria |
Details |
1. Persons living with diagnosed oral cancer and currently on treatment.
2. Participants not present at home even after two follow up visits during initial recruitment and post intervention follow up survey.
3. Those refusing consent for the study. |
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
Percentage change in number of screened population positive for both OSE & oral scrape cytology screening, population screened positive in OSE, number of OSE positive self referring themselves for oral scrape cytology screening, Proportion of population screened positive in OSE & underwent oral scrape cytology screening, number of cytology positive selfreferring & referral by ASHA, change in level of awareness, knowledge, attitude & skills, frequency of OSE ,proportion of calls to ASHA, delayed calls, population receiving pamphlets & videos from ASHA ,reach, adoption, fidelity & implementation cost. |
Baseline data collection starts at 0 months .
Follow up after 12 months |
|
Secondary Outcome
|
Outcome |
TimePoints |
no secondary outcomes |
no secondary outcomes |
|
Target Sample Size
|
Total Sample Size="240" Sample Size from India="240"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
01/01/2024 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
Introduction and Rationale- Oral cancer is sixth common malignancy globally, while in India, it is third most common malignancy with a five-year survival rate of 52% indicating that most of the cases are identified later at an advanced stage. Thus, early detection is critical for improving the survival rates. Oral cancers are usually preceded by potentially malignant disorders which are generally asymptomatic at their initiation and may be detected by clinicians on routine oral visual examination (OVE) and by people themselves through oral self examination (OSE). OSE has been endorsed by NPCDCS as well, which is the flagship programme of government of India for addressing NCDs. Screening is usually recommended once in 5 years but NFHS 4 and 5 data indicates low screening rates in Madhya Pradesh. Review of Indian studies have shown that, oral cancer screening through OSE and oral scrape cytology is a useful screening adjunct to conventional OVE for early detection of oral cancer and is simple, easy to use, minimal patient discomfort, good patient acceptance, non invasive , cost effective, less time consuming, minimum manpower and equipment requirement. Community Health Officers(CHOs) posted in sub centres and staff nurses posted in PHC with some training can easily be taught how to perform sample collection for oral scrape cytology-based screening for early identification of oral cancer. Primary objective 1.) To find out the effectiveness, and to conduct economic and implementation evaluation of an integrated public health intervention package (oral self-examination, oral scrape cytology based screening and m Health) for increasing screening for oral cancer among adults aged 30 years and above. 2.) To conduct a situational analysis to document oral cancer screening practices, and to understand barriers and facilitators with respect to screening, diagnosis, treatment and referral of oral cancer as reported by the different stakeholders involved. Secondary objective To find out the socio-demographic, clinical, behavioural, environmental and health system predictors of oral cancer screening. Methodolgy- mixed-methods intervention design with cluster randomized trial in community. Qualitative component includes in depth interviews (IDIs) and key informant interview (KIIs) and quantitative component includes cross-sectional survey and semi-structured interviews, questionnaire based survey and health facility survey to be carried out among the healthcare facilities (both government and private) of Bhopal and Raisen district on adults aged 30 years and above . Final sample is 240 i.e. 120 in each arm. ASHAs will be trained for OSE and CHOs for collection of oral scrape cytology sample by the candidate. The pragmatic cluster randomized trial will be conducted for nine months in three phases. Phase 1(situational analysis), phase 2 (implementation and trial of the complex intervention for oral cancer screening), phase 3(Evaluation of the intervention). Outcome measures will be percentage change in number of screened population, self referral practices, people undergoing oral scrape cytology and change in level of awareness, knowledge, attitude and skills between aged ≥ 30 years) in the intervention arm as compared to usual care arm. Ethical Consideration- LOP for thesis proposal has been obtained from institutional human ethics committee. |